Skip to main content
Clinical Trials/NCT00508066
NCT00508066CompletedPhase 4

Continuous Local Infusion of Anesthetic at the Incisional Site for Scoliosis Surgery

Shriners Hospitals for Children1 site in 1 country60 target enrollmentStarted: May 2007Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
VAS pain score

Study Overview

Brief Summary

The purpose of this study is to evaluate the effects of continuous local anesthetic delivery on the immediate post-op recovery of patients undergoing spinal fusion surgery for congenital or idiopathic scoliosis.

Detailed Description

Constant local analgesic infusion is a relatively new modality that provides a constant supply of medication without the need for repeat injections. This method has shown encouraging results with respect to pain levels, narcotic use, faster rehabilitation and shorter hospital stay in patients undergoing laparotomies, iliac crest bone graft harvest, and sternotomies. In addition, there have not been any reported complications when used in these scenarios.

We hope to confirm better pain control, less narcotic use (i.e. PCA), fewer narcotic side effects, better response to physical therapy and earlier discharge. Which may be generalized to the spinal surgery patient population as less pain and suffering and a better overall hospital course

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
8 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Clinical Diagnosis of Congenital Scoliosis
  • Clinical Diagnosis of Idiopathic Scoliosis
  • Anticipated Spinal Fusion Surgery

Exclusion Criteria

  • Less than 8 years of age

Arms & Interventions

Arm 1

Experimental

Subjects in arm 1 will intraoperatively have a continuous infusion catheter placed in the paraspinal musculature of the posterior spinal wound. Post-operatively, the catheter will infuse 0.25 - 0.5% (according to patient's weight) Bupivacaine at a rate of 4ml/hr for 72 hours. This is in addition to the standardized PCA pain management.

Intervention: Bupivacaine (Drug)

Arm 2

Placebo Comparator

Subjects in arm 2 will intraoperatively have a continuous infusion catheter placed in the paraspinal musculature of the posterior spinal wound. Post-operatively, the catheter will infuse normal saline at a rate of 4ml/hr for 72 hours. This is in addition to the standardized PCA pain management.

Intervention: Normal Saline (Drug)

Outcomes

Primary Outcomes

VAS pain score

Time Frame: 72 hours

Secondary Outcomes

  • Physical Therapy Progress(Post-op day 1, 2, 3)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Terri Green

Clinical Data Coordinator

Shriners Hospitals for Children

Study Sites (1)

Loading locations...

Similar Trials